Searched for
ORAL LIQUID FORMULATIONS
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- For risk-takers with long-term perspective: 10 small-cap stocks from different sectors with upside potential of up to 31%If you buy small-cap stocks today, are you taking a risk or managing it? To some it might appear you are taking a risk, but there is a high...
- Drug regulator drafts guidelines on high-risk solvents after tainted syrup deaths in kidsIndia's drug regulator is creating new rules for dangerous solvents in children's medicines. This follows tragic deaths linked to contamina...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...
- Rs 409 crore Sai Parenteral’s IPO issue opens for subscription. Check price band, GMP and to subscribe or notSai Parenteral's IPO opens for subscription, aiming to raise Rs 409 crore through a mix of fresh equity and an offer for sale. The company ...
- After cough syrup deaths, drug regulator moves to tighten rules on high-risk solvents; unlicensed village pharmacies also under scrutinyIndia's drug regulator is taking action after children died from contaminated cough syrups. They are looking into how to check the quality ...
- MP cough syrup deaths: Maharashtra FDA orders inspection of liquid oral formulationsFollowing the deaths of 20 children in Madhya Pradesh due to a contaminated cough syrup, the Maharashtra FDA has initiated a special drive....
- Akums enters into Rs 1750 crore contract to supply pharma products to EuropeAkums Drugs & Pharmaceuticals has signed a long-term contract worth Rs 1760 crore with an unnamed global pharmaceutical company to manufact...
- Akums Group inks pact worth 200 million euros for European marketAkums Group signed a long-term deal worth 200 million euros with a global pharma company. They will produce and supply oral liquid formulat...
- Quest Labs stock debuts with 60% premium on NSE SME platformQuest Laboratories made its debut on the NSE SME platform on Thursday, starting with a 60% premium. The stock opened at Rs 155, surpassing ...
- Zydus Lifesciences acquires UK-based LiqMeds Group for Rs 690 croreZydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026 depending on achievement of certain agreed milest...
- Suven Pharma acquires Hyderabad-based formulation maker for Rs 155 croreSuven will purchase100% of share capital from CPPL existing investors. Suven didn't provide details like annual turnover of the acquired as...
- Panacea's Baddi unit gets US FDA approvalDrug maker Panacea Biotec on Friday said its pharmaceutical facility at Baddi in Himachal Pradesh has received approval from US health regu...
- Ranbaxy partners with Validus to sell calcium drug in USRanbaxy Laboratories on Thursday said it has entered into an agreement with the US-based Validus Pharma for selling low cost versions of it...
- Pricey pills finally get pro-rata pricingThe drug price regulator has now introduced what it calls pro-rata pricing for injectibles, oral liquids, tablets and ointments.
Load More
